GenSight Biologics raised €32M in a Series A round in Apr 2013. The company is based in Paris, France. Investors in the round: Abingworth LLP, Index Ventures, Novartis Venture Fund. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €32M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
